rs863223413
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PS3_SupportingPP4_ModeratePP3PM2_SupportingPM1PS4PP1_Strong
This summary comes from the ClinGen Evidence Repository: The NM_000020.3: c.998G>T variant in ACVRL1 is a missense variant predicted to cause substitution of serine by isoleucine at amino acid 333 (p.Ser333Ile). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant has been reported in >4 probands with a phenotype consistent of HHT (PS4; Internal lab contributors). At least one patient's phenotype meets Curacao Criteria for HHT, and sequencing and large deletion/duplication analysis was performed for ENG and ACVRL1, which is highly specific for HHT (PP4_Moderate; Internal lab contributors). The variant has been reported to segregate with disease in a large HHT family (PP1_Strong; Internal lab contributors). This variant resides within a region, Arg329-Asn335 (catalytic loop), of ACVRL1 that is defined as a critical functional domain/residue by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel (PM1). The computational predictor REVEL gives a score of 0.975, which is above the threshold of ≥0.644, evidence that correlates with impact to ACVRL1 function (PP3). Additionally, western blot in HEK293T, COS7 and Hep3B mutant cells showed reduced surface expression of the variant protein and dominant-negative effect. Moreover, the variant induces embryonic dorsalization indicating that this variant impacts protein function (PS3_Supporting; PMID:16282348). In summary, this variant meets the criteria to be classified as pathogenic for Hereditary Hemorrhagic Telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: PM1, PM2_Supporting, PS4, PS3_Supporting, PP1_Strong, PP3, PP4_Moderate (specification version 1.0.0; 1/04/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA322708/MONDO:0010880/135
Frequency
Consequence
NM_000020.3 missense
Scores
Clinical Significance
Conservation
Publications
- telangiectasia, hereditary hemorrhagic, type 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
- hereditary hemorrhagic telangiectasiaInheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000020.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACVRL1 | NM_000020.3 | MANE Select | c.998G>T | p.Ser333Ile | missense | Exon 7 of 10 | NP_000011.2 | ||
| ACVRL1 | NM_001077401.2 | c.998G>T | p.Ser333Ile | missense | Exon 6 of 9 | NP_001070869.1 | |||
| ACVRL1 | NM_001406487.1 | c.998G>T | p.Ser333Ile | missense | Exon 8 of 11 | NP_001393416.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACVRL1 | ENST00000388922.9 | TSL:1 MANE Select | c.998G>T | p.Ser333Ile | missense | Exon 7 of 10 | ENSP00000373574.4 | ||
| ACVRL1 | ENST00000550683.5 | TSL:1 | c.1040G>T | p.Ser347Ile | missense | Exon 6 of 9 | ENSP00000447884.1 | ||
| ACVRL1 | ENST00000551576.6 | TSL:1 | c.998G>T | p.Ser333Ile | missense | Exon 8 of 11 | ENSP00000455848.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at